CD274 and neoplasm: Although different studies have used variable methods to define PD-L1 positivity in RCC (different antibodies in immunohistochemistry, tumor cell or immune cell positivity, positivity cut-off %), PD-L1 expression has unequivocally been an adverse prognostic feature.